Main Menu

Prostate Cancer Targeted Therapy Group 

Professor Johann de Bono’s team investigates new molecular targeted therapies to improve the treatment of patients with advanced prostate cancer.

Group leader

Professor Johann De Bono

Professor Johann De Bono

Divisional Head of Clinical Studies

Professor Johann de Bono is the Head of the Division of Clinical Studies and an international expert in the development of novel anticancer therapies against adult cancers. His team of runs one of the world’s largest phase I clinical trials units for cancer, with >100 staff including dedicated radiology and pathology staff; he also runs a separate team focused on improving prostate cancer care that have led pivotal phase III trials of several prostate cancer drugs including abiraterone, cabazitaxel, enzalutamide and olaparib as well more recently ipatasertib and lutetium-PSMA.

ORCID 0000-0002-2034-595X

Group members

Dr Juliet Carmichael

Clinical Fellow/Speciality Registrar +44 20 3437 6565

Emily Cross

Lead Data Manager +44 20 8722 4286

Bola Fadahunsi

Senior Compliance and Regulatory Manager +44 20 3437 3500

Kes Green

Clinical Data Manager +44 20 3437 6934

Dr Christina Guo

Honorary Appointment

Sam Legg

Senior Data Manager +44 20 8722 4191

Dr Arian Lundberg

Postdoctoral Training Fellow +44 20 3437 3647

Dr Vijaya Priyadarshini

Clinical Trial Coordinator Operational +44 20 3437 6904

Katie Russell-Rose

Clinical Trial Assistant +44 20 3437 6132

Sheena Vadgama

Senior Clinical Trials Coordinator +44 20 3437 6810